| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.66 | 0.008 | 0.725 | Spasmolytic | 0.725 0.005 DBMET03448 0.673 0.007 DBMET03452 0.696 0.006 DBMET03455 0.667 0.008 DBMET03449 0.678 0.007 DBMET03453 0.634 0.01 DBMET03454 0.634 0.01 DBMET03450 0.634 0.01 DBMET03451 | DBMET03448 | |
| 0.598 | 0.001 | 0.598 | Ceramide glucosyltransferase inhibitor | 0.255 0.001 DBMET03448 0.264 0.001 DBMET03452 0.327 0.001 DBMET03455 0.294 0.001 DBMET03449 0.304 0.001 DBMET03453 0.414 0.001 DBMET03454 0.414 0.001 DBMET03450 0.414 0.001 DBMET03451 | ||
| 0.568 | 0.019 | 0.684 | Vasodilator, peripheral | 0.6 0.016 DBMET03448 0.636 0.012 DBMET03452 0.684 0.007 DBMET03455 0.671 0.008 DBMET03449 0.61 0.015 DBMET03453 0.622 0.014 DBMET03454 0.622 0.014 DBMET03450 0.622 0.014 DBMET03451 | DBMET03455 | |
| 0.561 | 0.014 | 0.58 | Histamine release inhibitor | 0.517 0.023 DBMET03448 0.486 0.034 DBMET03452 0.526 0.021 DBMET03455 0.407 0.072 DBMET03449 0.423 0.064 DBMET03453 0.58 0.012 DBMET03454 0.58 0.012 DBMET03450 0.58 0.012 DBMET03451 | DBMET03451 | |
| 0.559 | 0.026 | 0.561 | Antiobesity | 0.561 0.026 DBMET03448 0.479 0.042 DBMET03452 0.494 0.039 DBMET03455 0.487 0.04 DBMET03449 0.454 0.048 DBMET03453 0.561 0.026 DBMET03454 0.561 0.026 DBMET03450 0.561 0.026 DBMET03451 | DBMET03451 | |
| 0.462 | 0.005 | 0.514 | Anesthetic local | 0.514 0.004 DBMET03448 0.443 0.005 DBMET03452 0.467 0.005 DBMET03455 0.406 0.006 DBMET03449 0.305 0.012 DBMET03453 0.243 0.021 DBMET03454 0.243 0.021 DBMET03450 0.243 0.021 DBMET03451 | DBMET03448 | |
| 0.47 | 0.014 | 0.487 | Psychostimulant | 0.308 0.041 DBMET03448 0.378 0.026 DBMET03452 0.362 0.029 DBMET03455 0.335 0.034 DBMET03449 0.359 0.03 DBMET03453 0.487 0.012 DBMET03454 0.487 0.012 DBMET03450 0.487 0.012 DBMET03451 | DBMET03451 | |
| 0.449 | 0.051 | 0.449 | Calcium channel L-type activator | 0.416 0.071 DBMET03448 0.404 0.079 DBMET03452 0.404 0.079 DBMET03455 0.428 0.064 DBMET03449 0.416 0.071 DBMET03453 0.433 0.06 DBMET03454 0.433 0.06 DBMET03450 0.433 0.06 DBMET03451 | ||
| 0.434 | 0.041 | 0.515 | Immunostimulant | 0.481 0.031 DBMET03448 0.465 0.034 DBMET03452 0.515 0.027 DBMET03455 0.414 0.046 DBMET03449 0.411 0.046 DBMET03453 0.457 0.036 DBMET03454 0.457 0.036 DBMET03450 0.457 0.036 DBMET03451 | DBMET03455 | |
| 0.43 | 0.046 | 0.43 | Calpain 2 inhibitor | 0.249 0.15 DBMET03448 0.289 0.121 DBMET03452 0.293 0.119 DBMET03455 0.372 0.076 DBMET03449 0.409 0.057 DBMET03453 0.296 0.117 DBMET03454 0.296 0.117 DBMET03450 0.296 0.117 DBMET03451 | ||
| 0.413 | 0.031 | 0.427 | Vasodilator, coronary | 0.42 0.029 DBMET03448 0.385 0.04 DBMET03452 0.427 0.028 DBMET03455 0.272 0.113 DBMET03449 0.278 0.107 DBMET03453 0.367 0.047 DBMET03454 0.367 0.047 DBMET03450 0.367 0.047 DBMET03451 | DBMET03455 | |
| 0.443 | 0.07 | 0.547 | Cyclophilin D inhibitor | 0.5 0.05 DBMET03448 0.455 0.065 DBMET03452 0.457 0.064 DBMET03455 0.389 0.097 DBMET03449 0.352 0.121 DBMET03453 0.547 0.038 DBMET03454 0.547 0.038 DBMET03450 0.547 0.038 DBMET03451 | DBMET03451 | |
| 0.369 | 0.009 | 0.369 | Peptidyltransferase inhibitor | 0.365 0.01 DBMET03448 0.355 0.011 DBMET03452 0.355 0.011 DBMET03455 0.353 0.012 DBMET03449 0.351 0.012 DBMET03453 0.368 0.01 DBMET03454 0.368 0.01 DBMET03450 0.368 0.01 DBMET03451 | ||
| 0.399 | 0.049 | 0.507 | Antithrombotic | 0.474 0.033 DBMET03448 0.466 0.034 DBMET03452 0.488 0.031 DBMET03455 0.43 0.042 DBMET03449 0.439 0.04 DBMET03453 0.507 0.028 DBMET03454 0.507 0.028 DBMET03450 0.507 0.028 DBMET03451 | DBMET03451 | |
| 0.386 | 0.087 | 0.386 | 5 Hydroxytryptamine release inhibitor | 0.325 0.139 DBMET03448 0.295 0.171 DBMET03452 0.34 0.124 DBMET03455 0.244 0.237 DBMET03453 0.292 0.174 DBMET03454 0.292 0.174 DBMET03450 0.292 0.174 DBMET03451 | ||
| 0.326 | 0.037 | 0.396 | Interleukin agonist | 0.345 0.03 DBMET03448 0.354 0.028 DBMET03452 0.396 0.019 DBMET03455 0.204 0.117 DBMET03449 0.205 0.116 DBMET03453 0.366 0.025 DBMET03454 0.366 0.025 DBMET03450 0.366 0.025 DBMET03451 | DBMET03455 | |
| 0.349 | 0.077 | 0.449 | Transcription factor NF kappa B inhibitor | 0.265 0.117 DBMET03448 0.347 0.078 DBMET03452 0.359 0.074 DBMET03455 0.449 0.053 DBMET03449 0.385 0.067 DBMET03453 0.355 0.075 DBMET03454 0.355 0.075 DBMET03450 0.355 0.075 DBMET03451 | DBMET03449 | |
| 0.301 | 0.03 | 0.32 | Calpain inhibitor | 0.231 0.083 DBMET03448 0.239 0.076 DBMET03452 0.247 0.068 DBMET03455 0.286 0.037 DBMET03449 0.32 0.023 DBMET03453 0.266 0.051 DBMET03454 0.266 0.051 DBMET03450 0.266 0.051 DBMET03451 | DBMET03453 | |
| 0.326 | 0.057 | 0.357 | Sodium/bile acid cotransporter inhibitor | 0.295 0.084 DBMET03448 0.299 0.08 DBMET03452 0.315 0.066 DBMET03455 0.275 0.103 DBMET03449 0.281 0.097 DBMET03453 0.357 0.036 DBMET03454 0.357 0.036 DBMET03450 0.357 0.036 DBMET03451 | DBMET03451 | |
| 0.315 | 0.065 | 0.435 | 5 Hydroxytryptamine release stimulant | 0.368 0.052 DBMET03448 0.435 0.039 DBMET03452 0.406 0.045 DBMET03455 0.173 0.149 DBMET03449 0.402 0.045 DBMET03453 | DBMET03452 | |
| 0.251 | 0.004 | 0.272 | Sphingomyelinase inhibitor | 0.224 0.006 DBMET03448 0.236 0.005 DBMET03452 0.272 0.004 DBMET03455 0.155 0.022 DBMET03449 0.167 0.018 DBMET03453 0.151 0.024 DBMET03454 0.151 0.024 DBMET03450 0.151 0.024 DBMET03451 | DBMET03455 | |
| 0.251 | 0.014 | 0.31 | Acetylcholine muscarinic antagonist | 0.168 0.035 DBMET03448 0.165 0.036 DBMET03452 0.166 0.036 DBMET03455 0.31 0.008 DBMET03449 0.212 0.022 DBMET03453 0.181 0.03 DBMET03454 0.181 0.03 DBMET03450 0.181 0.03 DBMET03451 | DBMET03449 | |
| 0.251 | 0.025 | 0.274 | Acetylcholine M1 receptor antagonist | 0.182 0.051 DBMET03448 0.188 0.048 DBMET03452 0.188 0.048 DBMET03455 0.274 0.02 DBMET03449 0.183 0.05 DBMET03453 0.18 0.052 DBMET03454 0.18 0.052 DBMET03450 0.18 0.052 DBMET03451 | DBMET03449 | |
| 0.295 | 0.077 | 0.337 | Interleukin 2 agonist | 0.309 0.068 DBMET03448 0.312 0.066 DBMET03452 0.326 0.057 DBMET03455 0.247 0.122 DBMET03449 0.253 0.115 DBMET03453 0.337 0.052 DBMET03454 0.337 0.052 DBMET03450 0.337 0.052 DBMET03451 | DBMET03451 | |
| 0.227 | 0.026 | 0.297 | Cholinergic antagonist | 0.132 0.063 DBMET03448 0.133 0.063 DBMET03452 0.134 0.062 DBMET03455 0.297 0.015 DBMET03449 0.266 0.018 DBMET03453 0.171 0.042 DBMET03454 0.171 0.042 DBMET03450 0.171 0.042 DBMET03451 | DBMET03449 | |
| 0.262 | 0.063 | 0.325 | Vasodilator | 0.325 0.04 DBMET03448 0.307 0.046 DBMET03452 0.319 0.042 DBMET03455 0.317 0.043 DBMET03449 0.241 0.074 DBMET03453 0.268 0.06 DBMET03454 0.268 0.06 DBMET03450 0.268 0.06 DBMET03451 | DBMET03448 | |
| 0.215 | 0.016 | 0.24 | Bronchodilator | 0.223 0.015 DBMET03448 0.182 0.021 DBMET03452 0.189 0.02 DBMET03455 0.24 0.014 DBMET03449 0.181 0.022 DBMET03453 0.196 0.019 DBMET03454 0.196 0.019 DBMET03450 0.196 0.019 DBMET03451 | DBMET03449 | |
| 0.221 | 0.026 | 0.28 | Acetylcholine antagonist | 0.127 0.064 DBMET03448 0.126 0.065 DBMET03452 0.128 0.064 DBMET03455 0.28 0.016 DBMET03449 0.26 0.018 DBMET03453 0.165 0.043 DBMET03454 0.165 0.043 DBMET03450 0.165 0.043 DBMET03451 | DBMET03449 | |
| 0.261 | 0.075 | 0.318 | Cardiotonic | 0.318 0.049 DBMET03448 0.273 0.068 DBMET03452 0.292 0.06 DBMET03455 0.19 0.129 DBMET03449 0.221 0.102 DBMET03453 0.226 0.098 DBMET03454 0.226 0.098 DBMET03450 0.226 0.098 DBMET03451 | DBMET03448 | |
| 0.297 | 0.117 | 0.416 | Immunosuppressant | 0.337 0.094 DBMET03448 0.332 0.096 DBMET03452 0.343 0.09 DBMET03455 0.416 0.057 DBMET03449 0.397 0.064 DBMET03453 0.311 0.108 DBMET03454 0.311 0.108 DBMET03450 0.311 0.108 DBMET03451 | DBMET03449 | |
| 0.232 | 0.074 | 0.232 | Neuropeptide Y2 antagonist | 0.216 0.094 DBMET03448 0.219 0.09 DBMET03452 0.205 0.111 DBMET03455 0.218 0.091 DBMET03449 0.209 0.105 DBMET03454 0.209 0.105 DBMET03450 0.209 0.105 DBMET03451 | ||
| 0.156 | 0.004 | 0.156 | Glucosylceramidase inhibitor | 0.106 0.007 DBMET03448 0.102 0.008 DBMET03452 0.13 0.005 DBMET03455 0.078 0.016 DBMET03449 0.083 0.014 DBMET03453 0.083 0.014 DBMET03454 0.083 0.014 DBMET03450 0.083 0.014 DBMET03451 | ||
| 0.162 | 0.012 | 0.169 | Adrenaline agonist | 0.169 0.011 DBMET03448 0.153 0.014 DBMET03452 0.164 0.012 DBMET03455 0.089 0.047 DBMET03449 0.094 0.042 DBMET03453 0.122 0.024 DBMET03454 0.122 0.024 DBMET03450 0.122 0.024 DBMET03451 | DBMET03448 | |
| 0.177 | 0.033 | 0.177 | Proteasome inhibitor | 0.165 0.038 DBMET03448 0.128 0.06 DBMET03452 0.148 0.048 DBMET03455 0.15 0.046 DBMET03449 0.138 0.053 DBMET03453 0.157 0.043 DBMET03454 0.157 0.043 DBMET03450 0.157 0.043 DBMET03451 | ||
| 0.158 | 0.017 | 0.239 | Electron transport complex I inhibitor | 0.165 0.014 DBMET03448 0.207 0.008 DBMET03452 0.239 0.006 DBMET03455 0.179 0.011 DBMET03449 0.236 0.006 DBMET03453 0.12 0.046 DBMET03454 0.12 0.046 DBMET03450 0.12 0.046 DBMET03451 | DBMET03455 | |
| 0.164 | 0.032 | 0.203 | Antiadrenergic | 0.203 0.024 DBMET03448 0.153 0.035 DBMET03452 0.164 0.032 DBMET03455 0.114 0.048 DBMET03449 0.111 0.049 DBMET03453 0.117 0.047 DBMET03454 0.117 0.047 DBMET03450 0.117 0.047 DBMET03451 | DBMET03448 | |
| 0.161 | 0.032 | 0.2 | Adrenaline antagonist | 0.2 0.023 DBMET03448 0.15 0.034 DBMET03452 0.162 0.032 DBMET03455 0.112 0.047 DBMET03449 0.109 0.049 DBMET03453 0.114 0.046 DBMET03454 0.114 0.046 DBMET03450 0.114 0.046 DBMET03451 | DBMET03448 | |
| 0.167 | 0.038 | 0.185 | Adenylate cyclase stimulant | 0.157 0.052 DBMET03448 0.156 0.053 DBMET03452 0.165 0.041 DBMET03455 0.131 0.1 DBMET03449 0.13 0.101 DBMET03453 0.185 0.022 DBMET03454 0.185 0.022 DBMET03450 0.185 0.022 DBMET03451 | DBMET03451 | |
| 0.138 | 0.012 | 0.222 | Acetylcholine M3 receptor antagonist | 0.068 0.033 DBMET03448 0.068 0.033 DBMET03452 0.064 0.037 DBMET03455 0.222 0.005 DBMET03449 0.115 0.015 DBMET03453 0.076 0.028 DBMET03454 0.076 0.028 DBMET03450 0.076 0.028 DBMET03451 | DBMET03449 | |
| 0.171 | 0.053 | 0.185 | Thiol protease inhibitor | 0.135 0.087 DBMET03448 0.151 0.067 DBMET03452 0.177 0.05 DBMET03455 0.185 0.045 DBMET03449 0.185 0.046 DBMET03453 0.165 0.057 DBMET03454 0.165 0.057 DBMET03450 0.165 0.057 DBMET03451 | DBMET03453 | |
| 0.243 | 0.13 | 0.293 | Cholesterol antagonist | 0.249 0.126 DBMET03448 0.215 0.152 DBMET03452 0.272 0.11 DBMET03455 0.293 0.096 DBMET03454 0.293 0.096 DBMET03450 0.293 0.096 DBMET03451 | DBMET03451 | |
| 0.153 | 0.043 | 0.18 | Adenylate cyclase inhibitor | 0.178 0.031 DBMET03448 0.139 0.053 DBMET03452 0.152 0.044 DBMET03455 0.098 0.086 DBMET03449 0.18 0.03 DBMET03454 0.18 0.03 DBMET03450 0.18 0.03 DBMET03451 | DBMET03451 | |
| 0.192 | 0.085 | 0.192 | Neurotrophic factor enhancer | 0.149 0.14 DBMET03455 0.155 0.131 DBMET03449 0.148 0.141 DBMET03454 0.148 0.141 DBMET03450 0.148 0.141 DBMET03451 | ||
| 0.221 | 0.118 | 0.268 | Gastrin inhibitor | 0.186 0.17 DBMET03455 0.182 0.176 DBMET03449 0.186 0.17 DBMET03453 0.268 0.059 DBMET03454 0.268 0.059 DBMET03450 0.268 0.059 DBMET03451 | DBMET03451 | |
| 0.298 | 0.196 | 0.298 | Caspase 9 stimulant | 0.288 0.208 DBMET03454 0.288 0.208 DBMET03450 0.288 0.208 DBMET03451 | ||
| 0.138 | 0.038 | 0.138 | Alpha 2c adrenoreceptor antagonist | |||
| 0.2 | 0.1 | 0.375 | Platelet antagonist | 0.202 0.099 DBMET03448 0.246 0.074 DBMET03452 0.242 0.076 DBMET03455 0.186 0.113 DBMET03449 0.165 0.13 DBMET03453 0.375 0.032 DBMET03454 0.375 0.032 DBMET03450 0.375 0.032 DBMET03451 | DBMET03451 | |
| 0.142 | 0.043 | 0.142 | Alpha 2b adrenoreceptor antagonist | |||
| 0.112 | 0.014 | 0.141 | Acetylcholine M5 receptor antagonist | 0.062 0.04 DBMET03448 0.063 0.039 DBMET03455 0.141 0.009 DBMET03449 0.073 0.028 DBMET03453 0.054 0.053 DBMET03454 0.054 0.053 DBMET03450 0.054 0.053 DBMET03451 | DBMET03449 | |
| 0.115 | 0.018 | 0.139 | Acetylcholine M2 receptor antagonist | 0.056 0.048 DBMET03448 0.06 0.045 DBMET03452 0.056 0.049 DBMET03455 0.139 0.013 DBMET03449 0.079 0.03 DBMET03453 0.053 0.051 DBMET03454 0.053 0.051 DBMET03450 0.053 0.051 DBMET03451 | DBMET03449 | |
| 0.17 | 0.073 | 0.293 | Growth hormone agonist | 0.173 0.071 DBMET03448 0.157 0.082 DBMET03452 0.157 0.082 DBMET03455 0.138 0.098 DBMET03449 0.142 0.094 DBMET03453 0.293 0.034 DBMET03454 0.293 0.034 DBMET03450 0.293 0.034 DBMET03451 | DBMET03451 | |
| 0.09 | 0.005 | 0.09 | Beta 2 adrenoreceptor agonist | 0.081 0.009 DBMET03448 0.081 0.008 DBMET03452 0.086 0.006 DBMET03455 0.071 0.017 DBMET03449 0.07 0.019 DBMET03453 0.076 0.012 DBMET03454 0.076 0.012 DBMET03450 0.076 0.012 DBMET03451 | ||
| 0.098 | 0.017 | 0.107 | Beta adrenoreceptor antagonist | 0.107 0.014 DBMET03448 0.084 0.024 DBMET03452 0.099 0.017 DBMET03455 0.065 0.047 DBMET03449 0.059 0.057 DBMET03453 0.073 0.034 DBMET03454 0.073 0.034 DBMET03450 0.073 0.034 DBMET03451 | DBMET03448 | |
| 0.114 | 0.034 | 0.114 | Toll-Like receptor 3 antagonist | 0.087 0.076 DBMET03448 0.089 0.072 DBMET03452 0.096 0.057 DBMET03455 0.091 0.068 DBMET03449 0.092 0.065 DBMET03453 0.086 0.079 DBMET03454 0.086 0.079 DBMET03450 0.086 0.079 DBMET03451 | ||
| 0.139 | 0.061 | 0.185 | Toll-Like receptor 2 antagonist | 0.128 0.07 DBMET03448 0.155 0.049 DBMET03452 0.185 0.031 DBMET03455 0.152 0.051 DBMET03454 0.152 0.051 DBMET03450 0.152 0.051 DBMET03451 | DBMET03455 | |
| 0.103 | 0.026 | 0.111 | Interferon agonist | 0.098 0.03 DBMET03448 0.091 0.037 DBMET03452 0.111 0.021 DBMET03455 0.086 0.043 DBMET03454 0.086 0.043 DBMET03450 0.086 0.043 DBMET03451 | DBMET03455 | |
| 0.159 | 0.084 | 0.162 | Antipruritic | 0.157 0.086 DBMET03455 0.162 0.082 DBMET03454 0.162 0.082 DBMET03450 0.162 0.082 DBMET03451 | DBMET03451 | |
| 0.138 | 0.071 | 0.161 | Neurotrophic factor | 0.144 0.064 DBMET03448 0.144 0.065 DBMET03452 0.161 0.05 DBMET03455 0.125 0.087 DBMET03449 0.119 0.096 DBMET03453 0.119 0.096 DBMET03454 0.119 0.096 DBMET03450 0.119 0.096 DBMET03451 | DBMET03455 | |
| 0.189 | 0.123 | 0.252 | Hypoglycemic | 0.232 0.088 DBMET03448 0.205 0.108 DBMET03452 0.21 0.103 DBMET03455 0.185 0.128 DBMET03453 0.252 0.076 DBMET03454 0.252 0.076 DBMET03450 0.252 0.076 DBMET03451 | DBMET03451 | |
| 0.218 | 0.158 | 0.32 | Apoptosis antagonist | 0.222 0.154 DBMET03448 0.264 0.114 DBMET03452 0.267 0.111 DBMET03455 0.32 0.073 DBMET03449 0.269 0.11 DBMET03453 0.305 0.082 DBMET03454 0.305 0.082 DBMET03450 0.305 0.082 DBMET03451 | DBMET03449 | |
| 0.064 | 0.006 | 0.064 | Lysophosphatidic acid 2 receptor antagonist | 0.029 0.024 DBMET03448 0.033 0.018 DBMET03452 0.047 0.009 DBMET03455 0.049 0.009 DBMET03454 0.049 0.009 DBMET03450 0.049 0.009 DBMET03451 | ||
| 0.096 | 0.039 | 0.096 | Histamine H2 receptor antagonist | 0.082 0.062 DBMET03455 | ||
| 0.076 | 0.019 | 0.1 | Sphingosine kinase inhibitor | 0.073 0.022 DBMET03448 0.097 0.009 DBMET03452 0.1 0.008 DBMET03455 0.072 0.023 DBMET03453 | DBMET03455 | |
| 0.079 | 0.024 | 0.084 | Interferon inducer | 0.075 0.029 DBMET03448 0.069 0.036 DBMET03452 0.084 0.021 DBMET03455 0.06 0.053 DBMET03454 0.06 0.053 DBMET03450 0.06 0.053 DBMET03451 | DBMET03455 | |
| 0.069 | 0.018 | 0.069 | Alpha-mannosidase inhibitor | 0.062 0.024 DBMET03448 0.056 0.033 DBMET03452 0.064 0.022 DBMET03455 0.06 0.026 DBMET03454 0.06 0.026 DBMET03450 0.06 0.026 DBMET03451 | ||
| 0.106 | 0.057 | 0.116 | Factor V inhibitor | 0.105 0.059 DBMET03448 0.103 0.063 DBMET03452 0.103 0.063 DBMET03455 0.102 0.065 DBMET03449 0.099 0.07 DBMET03453 0.116 0.043 DBMET03454 0.116 0.043 DBMET03450 0.116 0.043 DBMET03451 | DBMET03451 | |
| 0.131 | 0.085 | 0.155 | Cell wall synthesis inhibitor | 0.116 0.105 DBMET03455 0.155 0.061 DBMET03454 0.155 0.061 DBMET03450 0.155 0.061 DBMET03451 | DBMET03451 | |
| 0.056 | 0.011 | 0.059 | Beta adrenoreceptor agonist | 0.059 0.009 DBMET03448 0.054 0.013 DBMET03452 0.058 0.009 DBMET03455 0.044 0.035 DBMET03449 0.045 0.031 DBMET03453 0.049 0.021 DBMET03454 0.049 0.021 DBMET03450 0.049 0.021 DBMET03451 | DBMET03448 | |
| 0.069 | 0.027 | 0.075 | Beta 1 adrenoreceptor antagonist | 0.075 0.021 DBMET03448 0.058 0.037 DBMET03452 0.071 0.025 DBMET03455 | DBMET03448 | |
| 0.068 | 0.031 | 0.095 | Cathepsin E inhibitor | 0.073 0.027 DBMET03448 0.095 0.015 DBMET03452 0.083 0.021 DBMET03455 0.061 0.038 DBMET03449 0.063 0.037 DBMET03453 0.066 0.033 DBMET03454 0.066 0.033 DBMET03450 0.066 0.033 DBMET03451 | DBMET03452 | |
| 0.04 | 0.004 | 0.04 | Acid ceramidase inhibitor | 0.027 0.013 DBMET03448 0.029 0.01 DBMET03452 0.035 0.005 DBMET03455 0.025 0.019 DBMET03453 | ||
| 0.231 | 0.195 | 0.272 | Antibacterial | 0.266 0.162 DBMET03448 0.257 0.17 DBMET03452 0.272 0.157 DBMET03455 0.219 0.208 DBMET03453 | DBMET03455 | |
| 0.121 | 0.085 | 0.147 | Bone formation stimulant | 0.121 0.084 DBMET03448 0.14 0.068 DBMET03452 0.139 0.069 DBMET03455 0.144 0.064 DBMET03453 0.147 0.062 DBMET03454 0.147 0.062 DBMET03450 0.147 0.062 DBMET03451 | DBMET03451 | |
| 0.121 | 0.086 | 0.134 | Vanilloid 1 agonist | 0.12 0.088 DBMET03452 0.134 0.059 DBMET03455 0.127 0.071 DBMET03453 0.122 0.084 DBMET03454 0.122 0.084 DBMET03450 0.122 0.084 DBMET03451 | DBMET03455 | |
| 0.058 | 0.024 | 0.059 | Lysophosphatidic acid 3 receptor antagonist | 0.054 0.03 DBMET03455 0.059 0.024 DBMET03454 0.059 0.024 DBMET03450 0.059 0.024 DBMET03451 | DBMET03451 | |
| 0.076 | 0.042 | 0.08 | Phospholipase D inhibitor | 0.08 0.034 DBMET03454 0.08 0.034 DBMET03450 0.08 0.034 DBMET03451 | DBMET03451 | |
| 0.059 | 0.025 | 0.059 | 5 Hydroxytryptamine 4 antagonist | 0.049 0.04 DBMET03449 | ||
| 0.115 | 0.083 | 0.143 | Alpha-N-acetylglucosaminidase inhibitor | 0.125 0.073 DBMET03448 0.11 0.089 DBMET03452 0.11 0.089 DBMET03455 0.143 0.059 DBMET03454 0.143 0.059 DBMET03450 0.143 0.059 DBMET03451 | DBMET03451 | |
| 0.064 | 0.034 | 0.064 | Cathepsin L inhibitor | 0.057 0.042 DBMET03449 0.056 0.043 DBMET03453 | ||
| 0.102 | 0.074 | 0.102 | CDC-like kinase 3 inhibitor | 0.098 0.083 DBMET03449 | ||
| 0.056 | 0.028 | 0.056 | Beta 2 adrenoreceptor antagonist | 0.046 0.043 DBMET03448 0.045 0.044 DBMET03452 0.054 0.03 DBMET03455 | ||
| 0.051 | 0.024 | 0.068 | Mannosidase inhibitor | 0.054 0.021 DBMET03448 0.058 0.018 DBMET03452 0.068 0.012 DBMET03455 0.053 0.022 DBMET03454 0.053 0.022 DBMET03450 0.053 0.022 DBMET03451 | DBMET03455 | |
| 0.066 | 0.04 | 0.066 | Beta 3 adrenoreceptor antagonist | 0.065 0.044 DBMET03455 | ||
| 0.245 | 0.221 | 0.287 | Apoptosis agonist | 0.237 0.228 DBMET03448 0.249 0.216 DBMET03455 0.287 0.182 DBMET03449 0.262 0.202 DBMET03453 0.247 0.217 DBMET03454 0.247 0.217 DBMET03450 0.247 0.217 DBMET03451 | DBMET03449 | |
| 0.058 | 0.034 | 0.058 | Sphingosine kinase 2 inhibitor | |||
| 0.159 | 0.138 | 0.224 | Cyclic AMP phosphodiesterase inhibitor | 0.224 0.077 DBMET03448 0.163 0.132 DBMET03455 0.21 0.086 DBMET03449 | DBMET03448 | |
| 0.141 | 0.12 | 0.174 | Hepatoprotectant | 0.174 0.086 DBMET03448 0.151 0.109 DBMET03452 0.151 0.108 DBMET03455 0.162 0.097 DBMET03449 0.17 0.089 DBMET03453 0.173 0.087 DBMET03454 0.173 0.087 DBMET03450 0.173 0.087 DBMET03451 | DBMET03448 | |
| 0.044 | 0.024 | 0.044 | Plasmepsin II inhibitor | 0.042 0.026 DBMET03455 | ||
| 0.065 | 0.049 | 0.065 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.103 | 0.087 | 0.143 | Caspase 3 inhibitor | 0.108 0.078 DBMET03449 0.098 0.095 DBMET03453 0.143 0.033 DBMET03454 0.143 0.033 DBMET03450 0.143 0.033 DBMET03451 | DBMET03451 | |
| 0.09 | 0.075 | 0.113 | Protease inhibitor | 0.108 0.059 DBMET03448 0.109 0.057 DBMET03452 0.113 0.053 DBMET03455 0.105 0.061 DBMET03449 0.085 0.079 DBMET03453 0.093 0.071 DBMET03454 0.093 0.071 DBMET03450 0.093 0.071 DBMET03451 | DBMET03455 | |
| 0.041 | 0.025 | 0.041 | AMPA 4 receptor antagonist | 0.04 0.026 DBMET03454 0.04 0.026 DBMET03450 0.04 0.026 DBMET03451 | ||
| 0.08 | 0.066 | 0.08 | Alpha 2 adrenoreceptor antagonist | |||
| 0.027 | 0.014 | 0.027 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.016 DBMET03455 0.024 0.02 DBMET03454 0.024 0.02 DBMET03450 0.024 0.02 DBMET03451 | ||
| 0.048 | 0.035 | 0.053 | Cytokine production stimulant | 0.048 0.033 DBMET03448 0.046 0.042 DBMET03452 0.053 0.023 DBMET03455 0.052 0.024 DBMET03449 0.048 0.036 DBMET03453 | DBMET03455 | |
| 0.078 | 0.066 | 0.078 | Calcium antagonist | |||
| 0.056 | 0.045 | 0.057 | Carbonic anhydrase stimulant | 0.057 0.043 DBMET03454 0.057 0.043 DBMET03450 0.057 0.043 DBMET03451 | DBMET03451 | |
| 0.067 | 0.056 | 0.067 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.08 | 0.07 | 0.105 | Transcription factor NF kappa B stimulant | 0.081 0.068 DBMET03448 0.105 0.035 DBMET03449 0.082 0.066 DBMET03453 0.093 0.047 DBMET03454 0.093 0.047 DBMET03450 0.093 0.047 DBMET03451 | DBMET03449 | |
| 0.029 | 0.019 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 DBMET03448 0.029 0.018 DBMET03452 0.029 0.017 DBMET03455 0.027 0.023 DBMET03453 | ||
| 0.077 | 0.069 | 0.077 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.093 | 0.087 | 0.11 | Nav1.4 sodium channel blocker | 0.11 0.062 DBMET03454 0.11 0.062 DBMET03450 0.11 0.062 DBMET03451 | DBMET03451 | |
| 0.09 | 0.084 | 0.125 | Glutamate (mGluR7) agonist | 0.125 0.025 DBMET03454 0.125 0.025 DBMET03450 0.125 0.025 DBMET03451 | DBMET03451 | |
| 0.079 | 0.074 | 0.104 | Vanilloid agonist | 0.085 0.057 DBMET03452 0.093 0.042 DBMET03455 0.104 0.029 DBMET03453 | DBMET03453 | |
| 0.065 | 0.062 | 0.144 | Glutamate decarboxylase inhibitor | 0.066 0.06 DBMET03448 0.08 0.044 DBMET03449 0.071 0.053 DBMET03453 0.144 0.014 DBMET03454 0.144 0.014 DBMET03450 0.144 0.014 DBMET03451 | DBMET03451 | |
| 0.038 | 0.036 | 0.052 | Sphingosine kinase 1 inhibitor | 0.05 0.016 DBMET03452 0.052 0.015 DBMET03455 | DBMET03455 | |
| 0.059 | 0.057 | 0.118 | Neuraminidase (influenza) inhibitor | 0.065 0.043 DBMET03448 0.118 0.012 DBMET03452 0.067 0.039 DBMET03455 | DBMET03452 | |
| 0.143 | 0.143 | 0.18 | Insulin sensitizer | 0.166 0.112 DBMET03455 0.18 0.096 DBMET03454 0.18 0.096 DBMET03450 0.18 0.096 DBMET03451 | DBMET03451 | |
| 0.07 | 0.07 | 0.084 | Chymotrypsin inhibitor | 0.084 0.049 DBMET03449 0.077 0.059 DBMET03454 0.077 0.059 DBMET03450 0.077 0.059 DBMET03451 | DBMET03449 | |
| 0.124 | 0.125 | 0.144 | Interferon gamma antagonist | 0.144 0.086 DBMET03448 0.128 0.114 DBMET03455 0.135 0.101 DBMET03454 0.135 0.101 DBMET03450 0.135 0.101 DBMET03451 | DBMET03448 | |
| 0.012 | 0.014 | 0.021 | Integrin alphaVbeta6 antagonist | 0.021 0.005 DBMET03454 0.021 0.005 DBMET03450 0.021 0.005 DBMET03451 | DBMET03451 | |
| 0.056 | 0.058 | 0.057 | CDC25B inhibitor | 0.057 0.056 DBMET03449 | DBMET03449 | |
| 0.068 | 0.072 | 0.071 | Acetylcholine nicotinic antagonist | 0.071 0.067 DBMET03453 | DBMET03453 | |
| 0.114 | 0.118 | 0.17 | Thrombolytic | 0.148 0.083 DBMET03449 0.17 0.068 DBMET03454 0.17 0.068 DBMET03450 0.17 0.068 DBMET03451 | DBMET03451 | |
| 0.051 | 0.056 | 0.137 | Neuraminidase inhibitor | 0.061 0.042 DBMET03448 0.137 0.007 DBMET03452 0.071 0.033 DBMET03455 | DBMET03452 | |
| 0.03 | 0.034 | 0.033 | Calpain 1 inhibitor | 0.031 0.029 DBMET03449 0.033 0.023 DBMET03453 | DBMET03453 | |
| 0.131 | 0.135 | 0.208 | Angiogenesis stimulant | 0.208 0.091 DBMET03454 0.208 0.091 DBMET03450 0.208 0.091 DBMET03451 | DBMET03451 | |
| 0.051 | 0.056 | 0.079 | Glucagon-like peptide 1 agonist | 0.06 0.048 DBMET03448 0.079 0.036 DBMET03454 0.079 0.036 DBMET03450 0.079 0.036 DBMET03451 | DBMET03451 | |
| 0.214 | 0.22 | 0.235 | Analgesic | 0.235 0.197 DBMET03453 | DBMET03453 | |
| 0.046 | 0.053 | 0.054 | Vanilloid 2 antagonist | 0.054 0.033 DBMET03452 0.054 0.033 DBMET03455 0.049 0.044 DBMET03453 | DBMET03455 | |
| 0.116 | 0.123 | 0.137 | Phospholipase A2 inhibitor | 0.128 0.104 DBMET03455 0.122 0.113 DBMET03449 0.13 0.1 DBMET03453 0.137 0.09 DBMET03454 0.137 0.09 DBMET03450 0.137 0.09 DBMET03451 | DBMET03451 | |
| 0.06 | 0.069 | 0.077 | Cathepsin G inhibitor | 0.077 0.047 DBMET03454 0.077 0.047 DBMET03450 0.077 0.047 DBMET03451 | DBMET03451 | |
| 0.035 | 0.045 | 0.04 | Glycine transporter 2 inhibitor | 0.04 0.038 DBMET03454 0.04 0.038 DBMET03450 0.04 0.038 DBMET03451 | DBMET03451 | |
| 0.121 | 0.132 | 0.14 | Melanin inhibitor | 0.126 0.121 DBMET03452 0.14 0.096 DBMET03455 0.128 0.118 DBMET03449 | DBMET03455 | |
| 0.03 | 0.041 | 0.037 | Cholecystokinin B agonist | 0.037 0.027 DBMET03454 0.037 0.027 DBMET03450 0.037 0.027 DBMET03451 | DBMET03451 | |
| 0.082 | 0.094 | 0.088 | Nav1.1 sodium channel blocker | 0.088 0.084 DBMET03448 0.087 0.085 DBMET03455 | DBMET03448 | |
| 0.082 | 0.095 | 0.093 | Anabolic | 0.093 0.073 DBMET03449 | DBMET03449 | |
| 0.042 | 0.056 | 0.06 | Cathepsin D inhibitor | 0.051 0.041 DBMET03448 0.06 0.034 DBMET03452 0.059 0.035 DBMET03455 | DBMET03452 | |
| 0.038 | 0.053 | 0.075 | Neuropeptide agonist | 0.075 0.033 DBMET03448 0.046 0.045 DBMET03455 | DBMET03448 | |
| 0.063 | 0.078 | 0.075 | Somatostatin 1 agonist | 0.075 0.058 DBMET03448 | DBMET03448 | |
| 0.053 | 0.069 | 0.07 | Protease 3C (Human rhinovirus) inhibitor | 0.07 0.037 DBMET03449 | DBMET03449 | |
| 0.021 | 0.037 | 0.029 | Plasmepsin I inhibitor | 0.029 0.023 DBMET03455 | DBMET03455 | |
| 0.023 | 0.039 | 0.04 | Renin inhibitor | 0.039 0.024 DBMET03448 0.04 0.023 DBMET03452 0.039 0.024 DBMET03455 | DBMET03452 | |
| 0.043 | 0.063 | 0.053 | Leukotriene B4 antagonist | 0.051 0.043 DBMET03452 0.053 0.038 DBMET03455 0.053 0.038 DBMET03454 0.053 0.038 DBMET03450 0.053 0.038 DBMET03451 | DBMET03451 | |
| 0.022 | 0.043 | 0.032 | Calcitonin receptor agonist | 0.032 0.025 DBMET03454 0.032 0.025 DBMET03450 0.032 0.025 DBMET03451 | DBMET03451 | |
| 0.035 | 0.056 | 0.059 | Neuraminidase (Influenza A) inhibitor | 0.059 0.013 DBMET03452 | DBMET03452 | |
| 0.022 | 0.043 | 0.06 | Leukotriene A4 hydrolase inhibitor | 0.032 0.03 DBMET03453 0.06 0.016 DBMET03454 0.06 0.016 DBMET03450 0.06 0.016 DBMET03451 | DBMET03451 | |
| 0.029 | 0.054 | 0.044 | Calcium-independent phospholipase A2 inhibitor | 0.044 0.007 DBMET03449 0.044 0.006 DBMET03453 | DBMET03453 | |
| 0.163 | 0.19 | 0.18 | Transcription factor STAT3 inhibitor | 0.18 0.163 DBMET03448 | DBMET03448 | |
| 0.069 | 0.096 | 0.088 | Aminopeptidase B inhibitor | 0.088 0.074 DBMET03454 0.088 0.074 DBMET03450 0.088 0.074 DBMET03451 | DBMET03451 | |
| 0.019 | 0.047 | 0.034 | Prostaglandin D2 agonist | 0.034 0.017 DBMET03448 0.031 0.022 DBMET03452 0.034 0.017 DBMET03455 0.032 0.02 DBMET03454 0.032 0.02 DBMET03450 0.032 0.02 DBMET03451 | DBMET03455 | |
| 0.014 | 0.043 | 0.024 | Integrin alphaVbeta3 antagonist | 0.024 0.013 DBMET03454 0.024 0.013 DBMET03450 0.024 0.013 DBMET03451 | DBMET03451 | |
| 0.074 | 0.108 | 0.119 | Interleukin 1 beta converting enzyme inhibitor | 0.09 0.071 DBMET03453 0.119 0.036 DBMET03454 0.119 0.036 DBMET03450 0.119 0.036 DBMET03451 | DBMET03451 | |
| 0.08 | 0.115 | 0.115 | Mucolytic | 0.115 0.059 DBMET03454 0.115 0.059 DBMET03450 0.115 0.059 DBMET03451 | DBMET03451 | |
| 0.01 | 0.045 | 0.014 | Integrin beta6 antagonist | 0.014 0.011 DBMET03454 0.014 0.011 DBMET03450 0.014 0.011 DBMET03451 | DBMET03451 | |
| 0.052 | 0.087 | 0.074 | Aminopeptidase I inhibitor | 0.074 0.048 DBMET03454 0.074 0.048 DBMET03450 0.074 0.048 DBMET03451 | DBMET03451 | |
| 0.027 | 0.066 | 0.04 | HIV-1 protease inhibitor | 0.04 0.035 DBMET03452 0.039 0.036 DBMET03455 | DBMET03452 | |
| 0.167 | 0.207 | 0.197 | Tyrosine 3 hydroxylase inhibitor | 0.197 0.142 DBMET03454 0.197 0.142 DBMET03450 0.197 0.142 DBMET03451 | DBMET03451 | |
| 0.055 | 0.097 | 0.07 | Metalloproteinase-2 inhibitor | 0.07 0.065 DBMET03454 0.07 0.065 DBMET03450 0.07 0.065 DBMET03451 | DBMET03451 | |
| 0.049 | 0.091 | 0.067 | Acetylcholine M4 receptor antagonist | 0.067 0.061 DBMET03449 | DBMET03449 | |
| 0.016 | 0.058 | 0.028 | Caspase 2 inhibitor | 0.028 0.026 DBMET03454 0.028 0.026 DBMET03450 0.028 0.026 DBMET03451 | DBMET03451 | |
| 0.07 | 0.115 | 0.085 | Hematopoietic | 0.085 0.059 DBMET03454 0.085 0.059 DBMET03450 0.085 0.059 DBMET03451 | DBMET03451 | |
| 0.11 | 0.157 | 0.31 | Platelet adhesion inhibitor | 0.31 0.031 DBMET03449 0.145 0.112 DBMET03454 0.145 0.112 DBMET03450 0.145 0.112 DBMET03451 | DBMET03449 | |
| 0.044 | 0.093 | 0.072 | Catalase inhibitor | 0.072 0.053 DBMET03454 0.072 0.053 DBMET03450 0.072 0.053 DBMET03451 | DBMET03451 | |
| 0.006 | 0.055 | 0.012 | Calcium-dependent phospholipase A2 inhibitor | 0.012 0.009 DBMET03449 0.012 0.01 DBMET03453 | DBMET03453 | |
| 0.014 | 0.065 | 0.046 | Histone deacetylase 4 inhibitor | 0.046 0.014 DBMET03453 | DBMET03453 | |
| 0.125 | 0.176 | 0.142 | Neurotensin receptor agonist | 0.142 0.122 DBMET03454 0.142 0.122 DBMET03450 0.142 0.122 DBMET03451 | DBMET03451 | |
| 0.041 | 0.092 | 0.058 | Leukotriene antagonist | 0.058 0.054 DBMET03454 0.058 0.054 DBMET03450 0.058 0.054 DBMET03451 | DBMET03451 | |
| 0.011 | 0.063 | 0.055 | Histone deacetylase 10 inhibitor | 0.055 0.01 DBMET03453 | DBMET03453 | |
| 0.075 | 0.128 | 0.101 | Phosphodiesterase 6D inhibitor | 0.087 0.084 DBMET03448 0.101 0.05 DBMET03452 0.094 0.066 DBMET03455 | DBMET03452 | |
| 0.16 | 0.213 | 0.227 | Transcription factor STAT inhibitor | 0.227 0.105 DBMET03448 | DBMET03448 | |
| 0.1 | 0.154 | 0.125 | Papain-like protease (SARS coronavirus) inhibitor | 0.125 0.069 DBMET03448 0.122 0.076 DBMET03452 0.122 0.076 DBMET03455 | DBMET03448 | |
| 0.04 | 0.095 | 0.056 | Sphingosine 1-phosphate receptor 5 agonist | 0.056 0.032 DBMET03454 0.056 0.032 DBMET03450 0.056 0.032 DBMET03451 | DBMET03451 | |
| 0.075 | 0.13 | 0.121 | Toll-Like receptor 4 antagonist | 0.096 0.076 DBMET03452 0.108 0.057 DBMET03455 0.121 0.043 DBMET03453 | DBMET03453 | |
| 0.083 | 0.139 | 0.142 | Cell adhesion inhibitor | 0.142 0.052 DBMET03454 0.142 0.052 DBMET03450 0.142 0.052 DBMET03451 | DBMET03451 | |
| 0.066 | 0.122 | 0.118 | Expectorant | 0.118 0.052 DBMET03448 0.114 0.055 DBMET03452 0.098 0.071 DBMET03455 0.104 0.064 DBMET03454 0.104 0.064 DBMET03450 0.104 0.064 DBMET03451 | DBMET03448 | |
| 0.062 | 0.118 | 0.101 | Mediator release inhibitor | 0.101 0.069 DBMET03449 | DBMET03449 | |
| 0.016 | 0.076 | 0.046 | GP IIb/IIIa receptor antagonist | 0.046 0.036 DBMET03454 0.046 0.036 DBMET03450 0.046 0.036 DBMET03451 | DBMET03451 | |
| 0.045 | 0.105 | 0.064 | Caspase 9 inhibitor | 0.064 0.039 DBMET03454 0.064 0.039 DBMET03450 0.064 0.039 DBMET03451 | DBMET03451 | |
| 0.116 | 0.181 | 0.328 | Hypolipemic | 0.172 0.116 DBMET03448 0.319 0.043 DBMET03452 0.328 0.041 DBMET03455 | DBMET03455 | |
| 0.015 | 0.082 | 0.043 | Integrin antagonist | 0.043 0.03 DBMET03454 0.043 0.03 DBMET03450 0.043 0.03 DBMET03451 | DBMET03451 | |
| 0.062 | 0.131 | 0.081 | ATPase (Vacuolar H+) inhibitor | 0.081 0.075 DBMET03448 0.081 0.075 DBMET03455 | DBMET03455 | |
| 0.018 | 0.09 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET03455 | DBMET03455 | |
| 0.111 | 0.182 | 0.146 | P-glycoprotein inhibitor | 0.146 0.124 DBMET03452 0.146 0.124 DBMET03455 | DBMET03455 | |
| 0.011 | 0.085 | 0.039 | Histone deacetylase class IIa inhibitor | 0.039 0.017 DBMET03453 | DBMET03453 | |
| 0.009 | 0.094 | 0.049 | Histone deacetylase 5 inhibitor | 0.049 0.017 DBMET03453 | DBMET03453 | |
| 0.007 | 0.095 | 0.053 | Histone deacetylase 3 inhibitor | 0.053 0.01 DBMET03453 | DBMET03453 | |
| 0.074 | 0.163 | 0.109 | Lipid peroxidase inhibitor | 0.109 0.105 DBMET03448 | DBMET03448 | |
| 0.1 | 0.189 | 0.217 | Interleukin antagonist | 0.217 0.075 DBMET03448 0.138 0.127 DBMET03452 0.145 0.122 DBMET03455 0.18 0.096 DBMET03454 0.18 0.096 DBMET03450 0.18 0.096 DBMET03451 | DBMET03448 | |
| 0.013 | 0.103 | 0.05 | Histone deacetylase 11 inhibitor | 0.05 0.013 DBMET03453 | DBMET03453 | |
| 0.013 | 0.103 | 0.05 | Histone deacetylase class IV inhibitor | 0.05 0.013 DBMET03453 | DBMET03453 | |
| 0.027 | 0.119 | 0.037 | Integrin alpha1beta1 antagonist | 0.037 0.032 DBMET03454 0.037 0.032 DBMET03450 0.037 0.032 DBMET03451 | DBMET03451 | |
| 0.009 | 0.105 | 0.033 | Histone deacetylase class II inhibitor | 0.033 0.016 DBMET03453 | DBMET03453 | |
| 0.02 | 0.125 | 0.079 | Prostaglandin EP2 antagonist | 0.069 0.034 DBMET03452 0.079 0.027 DBMET03455 0.054 0.047 DBMET03454 0.054 0.047 DBMET03450 0.054 0.047 DBMET03451 | DBMET03455 | |
| 0.008 | 0.114 | 0.028 | Histone deacetylase 6 inhibitor | 0.028 0.016 DBMET03453 | DBMET03453 | |
| 0.211 | 0.317 | 0.288 | Antiinflammatory | 0.279 0.236 DBMET03448 0.288 0.226 DBMET03449 | DBMET03449 | |
| 0.008 | 0.115 | 0.029 | Histone deacetylase class IIb inhibitor | 0.029 0.016 DBMET03453 | DBMET03453 | |
| 0.05 | 0.157 | 0.082 | Cell adhesion molecule inhibitor | 0.082 0.051 DBMET03454 0.082 0.051 DBMET03450 0.082 0.051 DBMET03451 | DBMET03451 | |
| 0.011 | 0.129 | 0.066 | Histone deacetylase 2 inhibitor | 0.066 0.012 DBMET03453 | DBMET03453 | |
| 0.037 | 0.183 | 0.069 | Glutamate dehydrogenase inhibitor | 0.069 0.058 DBMET03454 0.069 0.058 DBMET03450 0.069 0.058 DBMET03451 | DBMET03451 | |
| 0.081 | 0.24 | 0.195 | Insulin secretagoues | 0.195 0.038 DBMET03448 0.12 0.112 DBMET03454 0.12 0.112 DBMET03450 0.12 0.112 DBMET03451 | DBMET03448 | |
| 0.074 | 0.234 | 0.121 | Farnesoid X receptor antagonist | 0.121 0.101 DBMET03449 | DBMET03449 | |
| 0.007 | 0.176 | 0.039 | Histone deacetylase 1 inhibitor | 0.039 0.013 DBMET03453 | DBMET03453 | |
| 0.062 | 0.236 | 0.101 | Folate antagonist | 0.101 0.063 DBMET03454 0.101 0.063 DBMET03450 0.101 0.063 DBMET03451 | DBMET03451 | |
| 0.118 | 0.308 | 0.224 | Immunomodulator | 0.224 0.138 DBMET03448 | DBMET03448 | |
| 0.11 | 0.36 | 0.19 | Insulysin inhibitor | 0.19 0.172 DBMET03454 0.19 0.172 DBMET03450 0.19 0.172 DBMET03451 | DBMET03451 | |
| 0.021 | 0.291 | 0.063 | Prostaglandin F2 alpha antagonist | 0.057 0.051 DBMET03452 0.063 0.042 DBMET03455 | DBMET03455 | |
| 0.083 | 0.402 | 0.143 | Catenin beta inhibitor | 0.143 0.123 DBMET03454 0.143 0.123 DBMET03450 0.143 0.123 DBMET03451 | DBMET03451 | |
| 0.004 | 0.351 | 0.039 | HMG CoA reductase inhibitor | 0.039 0.015 DBMET03452 0.039 0.015 DBMET03455 | DBMET03455 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |